Clinical Trial Update: Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating Nab-Paclitaxel in advanced squamous cell carcinoma of the lung.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Chinese Society of Lung Cancer | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED